Capital Analysts, LLC Johnson & Johnson Transaction History

Capital Analysts, LLC

  • $2.45 Billion
  • Q3 2024

A detailed history of Capital Analysts, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Capital Analysts, LLC holds 42,447 shares of JNJ stock, worth $6.58 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
42,447
Previous 40,276 5.39%
Holding current value
$6.58 Million
Previous $5.89 Million 16.85%
% of portfolio
0.28%
Previous 0.26%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$145.48 - $167.38 $315,837 - $363,381
2,171 Added 5.39%
42,447 $6.88 Million
Q2 2024

Aug 14, 2024
BUY
$144.38 - $157.78 $136,005 - $148,628
942 Added 2.39%
40,276 $5.89 Million
Q1 2024

May 14, 2024
BUY
$155.22 - $162.74 $63,019 - $66,072
406 Added 1.04%
39,334 $6.22 Million
Q4 2023

Jan 30, 2024
BUY
$145.6 - $158.88 $81,099 - $88,496
557 Added 1.45%
38,928 $6.1 Million
Q3 2023

Nov 13, 2023
SELL
$155.75 - $174.48 $2,024 - $2,268
-13 Reduced 0.03%
38,371 $5.98 Million
Q2 2023

Aug 11, 2023
BUY
$154.35 - $166.11 $31,024 - $33,388
201 Added 0.53%
38,384 $6.35 Million
Q1 2023

May 05, 2023
BUY
$151.05 - $180.26 $720,357 - $859,659
4,769 Added 14.27%
38,183 $5.92 Million
Q4 2022

Feb 08, 2023
BUY
$160.2 - $179.79 $22,588 - $25,350
141 Added 0.42%
33,414 $5.9 Million
Q3 2022

Nov 14, 2022
BUY
$161.33 - $179.52 $558,524 - $621,498
3,462 Added 11.61%
33,273 $5.44 Million
Q2 2022

Aug 12, 2022
BUY
$168.19 - $186.01 $35,656 - $39,434
212 Added 0.72%
29,811 $5.29 Million
Q1 2022

May 12, 2022
BUY
$158.14 - $179.59 $57,562 - $65,370
364 Added 1.25%
29,599 $5.25 Million
Q4 2021

Feb 10, 2022
SELL
$155.93 - $173.01 $57,694 - $64,013
-370 Reduced 1.25%
29,235 $5 Million
Q3 2021

Nov 04, 2021
BUY
$161.5 - $179.47 $57,009 - $63,352
353 Added 1.21%
29,605 $4.78 Million
Q2 2021

Nov 15, 2021
SELL
$159.48 - $171.07 $566,951 - $608,153
-3,555 Reduced 10.84%
29,252 $4.82 Million
Q2 2021

Aug 05, 2021
BUY
$159.48 - $171.07 $470,465 - $504,656
2,950 Added 9.88%
32,807 $5.4 Million
Q1 2021

May 17, 2021
BUY
$153.07 - $170.48 $903,878 - $1.01 Million
5,905 Added 24.65%
29,857 $4.91 Million
Q4 2020

Feb 16, 2021
BUY
$137.11 - $157.38 $16,453 - $18,885
120 Added 0.5%
23,952 $3.77 Million
Q3 2020

Nov 12, 2020
SELL
$140.38 - $153.83 $59,380 - $65,070
-423 Reduced 1.74%
23,832 $3.55 Million
Q2 2020

Aug 07, 2020
SELL
$128.81 - $155.51 $57,449 - $69,357
-446 Reduced 1.81%
24,255 $3.41 Million
Q1 2020

May 08, 2020
BUY
$111.14 - $153.99 $2.15 Million - $2.97 Million
19,301 Added 357.43%
24,701 $3.24 Million
Q4 2019

Feb 12, 2020
BUY
$127.5 - $146.44 $55,462 - $63,701
435 Added 8.76%
5,400 $788,000
Q3 2019

Nov 12, 2019
SELL
$126.95 - $142.14 $53,826 - $60,267
-424 Reduced 7.87%
4,965 $642,000
Q2 2019

Aug 13, 2019
BUY
$131.15 - $144.24 $132,199 - $145,393
1,008 Added 23.01%
5,389 $751,000
Q1 2019

May 13, 2019
BUY
$125.72 - $139.79 $46,642 - $51,862
371 Added 9.25%
4,381 $612,000
Q4 2018

Feb 13, 2019
SELL
$122.84 - $147.84 $3.45 Million - $4.15 Million
-28,071 Reduced 87.5%
4,010 $518,000
Q3 2018

Nov 07, 2018
BUY
$121.58 - $142.88 $138,844 - $163,168
1,142 Added 3.69%
32,081 $0
Q2 2018

Aug 03, 2018
BUY
$119.4 - $131.76 $157,846 - $174,186
1,322 Added 4.46%
30,939 $0
Q1 2018

May 14, 2018
BUY
$125.1 - $148.14 $242,944 - $287,687
1,942 Added 7.02%
29,617 $3.8 Million
Q4 2017

Feb 14, 2018
BUY
$131.22 - $143.62 $3.38 Million - $3.7 Million
25,735 Added 1326.55%
27,675 $3.87 Million
Q4 2017

Feb 12, 2018
SELL
$131.22 - $143.62 $3.27 Million - $3.58 Million
-24,949 Reduced 92.79%
1,940 $153,000
Q3 2017

Nov 06, 2017
BUY
$129.47 - $135.38 $3.48 Million - $3.64 Million
26,889
26,889 $3.5 Million

Others Institutions Holding JNJ

# of Institutions
4,272
Shares Held
1.68B
Call Options Held
17.6M
Put Options Held
14.5M
View Full List

About JOHNSON & JOHNSON

JNJ Quotes by TradingView
  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $405B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Capital Analysts, LLC Portfolio

Follow Capital Analysts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Analysts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Analysts, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email